Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NCT05041309 is registered in ClinicalTrials.gov with Kite, A Gilead Company as lead sponsor.

NCT NCT05041309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05041309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
Lead sponsor
Kite, A Gilead Company
Phase
Observational
Overall status
Enrolling by invitation
Start date
December 15, 2021
Completion date
December 31, 2040
Enrollment
1,500 (estimated)
Sites
91

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, solid and hematological malignancies